KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Change in Taxes: 2011-2012

Historic Change in Taxes for Vertex Pharmaceuticals (VRTX) over the last 1 years, with Dec 2012 value amounting to -$3.2 million.

  • Vertex Pharmaceuticals' Change in Taxes fell 236.03% to -$3.2 million in Q4 2012 from the same period last year, while for Dec 2012 it was -$9.0 million, marking a year-over-year change of. This contributed to the annual value of -$11.4 million for FY2012, which is 194.08% down from last year.
  • Latest data reveals that Vertex Pharmaceuticals reported Change in Taxes of -$3.2 million as of Q4 2012, which was down 185.99% from $3.7 million recorded in Q3 2012.
  • In the past 5 years, Vertex Pharmaceuticals' Change in Taxes ranged from a high of $3.7 million in Q3 2012 and a low of -$11.9 million during Q1 2012.
  • In the last 2 years, Vertex Pharmaceuticals' Change in Taxes had a median value of -$3.2 million in 2012 and averaged -$2.9 million.
  • Over the last 5 years, Vertex Pharmaceuticals' Change in Taxes had its largest YoY gain of 167.25% in 2012, and its largest YoY loss of 236.03% in 2012.
  • Vertex Pharmaceuticals' Change in Taxes (Quarterly) stood at $2.3 million in 2011, then slumped by 236.03% to -$3.2 million in 2012.
  • Its last three reported values are -$3.2 million in Q4 2012, $3.7 million for Q3 2012, and -$11.9 million during Q1 2012.